EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Placental Senescence and the Two‐Stage Model of Preeclampsia

Meryam Sugulle, Bendik S Fiskå, Daniel Pitz Jacobsen, Heidi Elisabeth Fjeldstad, Anne Cathrine Staff

American Journal of Reproductive Immunology · 2024-07 · 92 (1)

DOI: 10.1111/aji.13904 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 25.07.2024. Verfasst von Meryam Sugulle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Pre-Eclampsia, Placenta, Cellular Senescence. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this review, we summarize how an increasingly stressed and aging placenta contributes to the maternal clinical signs of preeclampsia, a potentially lethal pregnancy complication. The pathophysiology of preeclampsia has been conceptualized in the two‐stage model. Originally, highlighting the importance of poor placentation for early‐onset preeclampsia, the revised two‐stage model explains late‐onset preeclampsia as well, which is often preceded by normal placentation. We discuss how cellular senescence in the placenta may fit with the framework of the revised two‐stage model of preeclampsia pathophysiology and summarize potential cellular and molecular mechanisms, including effects on placental and maternal endothelial function. Cellular senescence may occur in response to inflammatory processes and oxidative, mitochondrial, or endoplasmic reticulum stress and chronic stress induce accelerated, premature placental senescence. In preeclampsia, both circulating and tissue‐based senescence markers are present. We suggest that aspirin prophylaxis, commonly recommended from the first trimester onward for women at risk of preeclampsia, may affect placentation and possibly mechanisms of placental senescence, thus attenuating the risk of preeclampsia developing clinically. We propose that biomarkers of placental dysfunction and senescence may contribute to altered preventive strategies, including discontinuation of aspirin at week 24–28 depending on placenta‐associated biomarker risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaPlacentaCellular SenescenceHumansPregnancyFemaleBiomarkersPlacentationAnimalsAspirin

Stichwörter der Autor:innen

DNA damagecellular senescenceoxidative stressplacental agingpreeclampsiasenescence‐associated secretory phenotypetelomere

Substanzen

BiomarkersAspirin

Autor:innen und Institutionen

  • Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway.

Zitieren

APA

Sugulle, M., Fiskå, B. S., Jacobsen, D. P., Fjeldstad, H. E., & Staff, A. C. (2024). Placental Senescence and the Two‐Stage Model of Preeclampsia. American Journal of Reproductive Immunology, 92(1). https://doi.org/10.1111/aji.13904

Vancouver

Sugulle M, Fiskå BS, Jacobsen DP, Fjeldstad HE, Staff AC. Placental Senescence and the Two‐Stage Model of Preeclampsia. American Journal of Reproductive Immunology. 2024;92(1). doi:10.1111/aji.13904

BibTeX
@article{Sugulle2024,
  author = {Sugulle, Meryam and Fiskå, Bendik S and Jacobsen, Daniel Pitz and Fjeldstad, Heidi Elisabeth and Staff, Anne Cathrine},
  title = {Placental Senescence and the Two‐Stage Model of Preeclampsia},
  journal = {American Journal of Reproductive Immunology},
  year = {2024},
  volume = {92},
  number = {1},
  doi = {10.1111/aji.13904}
}
Kostenlos starten →